BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35999655)

  • 1. CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Wei W; Song Z; Yang Y
    Aesthet Surg J; 2023 Feb; 43(2):137-146. PubMed ID: 35999655
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonmalignant CD30+ Cells in Contralateral Peri-Implant Capsule of Patient With BIA-ALCL: A Premalignant Step?
    Kadin ME; Xu H; Hunsicker LM; Guan Y
    Aesthet Surg J; 2022 Jan; 42(2):NP125-NP129. PubMed ID: 33944901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 is produced by tumor cells in breast implant-associated anaplastic large cell lymphoma: implications for pathogenesis.
    Kadin ME; Morgan J; Xu H; Epstein AL; Sieber D; Hubbard BA; Adams WP; Bacchi CE; Goes JCS; Clemens MW; Medeiros LJ; Miranda RN
    Hum Pathol; 2018 Aug; 78():54-62. PubMed ID: 29689246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Commentary on: CD30 Regulation of IL-13-STAT6 Pathway in Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Turner SD
    Aesthet Surg J; 2023 Feb; 43(2):147-149. PubMed ID: 36380464
    [No Abstract]   [Full Text] [Related]  

  • 5. What Cytokines Can Tell Us About the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Kadin ME
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S28-S35. PubMed ID: 30715174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of a CD30 Enzyme-Linked Immunosorbant Assay for the Rapid Detection of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Hanson SE; Hassid VJ; Branch-Brooks C; Liu J; Kadin ME; Miranda R; Butler CE; Clemens MW
    Aesthet Surg J; 2020 Jan; 40(2):149-153. PubMed ID: 30789639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarkers Provide Clues to Early Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Deva A; Xu H; Morgan J; Khare P; MacLeod RA; Van Natta BW; Adams WP; Brody GS; Epstein AL
    Aesthet Surg J; 2016 Jul; 36(7):773-81. PubMed ID: 26979456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell of Origin and Immunologic Events in the Pathogenesis of Breast Implant-Associated Anaplastic Large-Cell Lymphoma.
    Turner SD; Inghirami G; Miranda RN; Kadin ME
    Am J Pathol; 2020 Jan; 190(1):2-10. PubMed ID: 31610171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Breast implant-associated ALK-negative anaplastic large cell lymphoma: a case report and discussion of possible pathogenesis.
    George EV; Pharm J; Houston C; Al-Quran S; Brian G; Dong H; Hai W; Reeves W; Yang LJ
    Int J Clin Exp Pathol; 2013; 6(8):1631-42. PubMed ID: 23923082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. UK Guidelines on the Diagnosis and Treatment of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) on behalf of the Medicines and Healthcare products Regulatory Agency (MHRA) Plastic, Reconstructive and Aesthetic Surgery Expert Advisory Group (PRASEAG).
    Turton P; El-Sharkawi D; Lyburn I; Sharma B; Mahalingam P; Turner SD; MacNeill F; Johnson L; Hamilton S; Burton C; Mercer N
    J Plast Reconstr Aesthet Surg; 2021 Jan; 74(1):13-29. PubMed ID: 33483089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction in anaplastic large cell lymphoma cells (ALCL) mediated by the tumor necrosis factor receptor CD30.
    Schneider C; Stöhr D; Merz H; Hübinger G
    Leuk Lymphoma; 2004 May; 45(5):1009-15. PubMed ID: 15291361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Kadin ME; Morgan J; Xu H; Glicksman CA
    Aesthet Surg J; 2017 Jul; 37(7):771-775. PubMed ID: 28402493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of flow cytometry and cytology to differentiate breast implant-associated anaplastic large cell lymphoma from reactive seromas in Brazilian patients.
    De Azambuja AP; Gevert F; Oliveira RM; Sebastião AP; Groth AK
    Cytometry B Clin Cytom; 2022 Jul; 102(4):312-316. PubMed ID: 34791787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    Oishi N; Miranda RN; Feldman AL
    Aesthet Surg J; 2019 Jan; 39(Suppl_1):S14-S20. PubMed ID: 30715169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does Breast Implant-Associated ALCL Begin as a Lymphoproliferative Disorder?
    Kadin ME; Adams WP; Inghirami G; Di Napoli A
    Plast Reconstr Surg; 2020 Jan; 145(1):30e-38e. PubMed ID: 31577659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of p38 mitogen-activated protein kinase unmasks a CD30-triggered apoptotic pathway in anaplastic large cell lymphoma cells.
    Krysov SV; Rowley TF; Al-Shamkhani A
    Mol Cancer Ther; 2007 Feb; 6(2):703-11. PubMed ID: 17308066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): an overview of presentation and pathogenesis and guidelines for pathological diagnosis and management.
    Jones JL; Hanby AM; Wells C; Calaminici M; Johnson L; Turton P; Deb R; Provenzano E; Shaaban A; Ellis IO; Pinder SE;
    Histopathology; 2019 Dec; 75(6):787-796. PubMed ID: 31166611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Breast implant-associated anaplastic large cell lymphoma: two distinct clinicopathological variants with different outcomes.
    Laurent C; Delas A; Gaulard P; Haioun C; Moreau A; Xerri L; Traverse-Glehen A; Rousset T; Quintin-Roue I; Petrella T; Emile JF; Amara N; Rochaix P; Chenard-Neu MP; Tasei AM; Menet E; Chomarat H; Costes V; Andrac-Meyer L; Michiels JF; Chassagne-Clement C; de Leval L; Brousset P; Delsol G; Lamant L
    Ann Oncol; 2016 Feb; 27(2):306-14. PubMed ID: 26598546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytological features of breast implant-associated anaplastic large cell lymphoma in pleural effusion.
    D'Alessandris N; Lucatelli P; Tripodi D; Amabile MI; Ascoli V
    Diagn Cytopathol; 2019 Nov; 47(11):1213-1217. PubMed ID: 31348611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spontaneous Regression and Resolution of Breast Implant-Associated Anaplastic Large Cell Lymphoma: Implications for Research, Diagnosis and Clinical Management.
    Fleming D; Stone J; Tansley P
    Aesthetic Plast Surg; 2018 Jun; 42(3):672-678. PubMed ID: 29445921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.